Genomenon Acquires Boston Genetics to Accelerate Human Genome Care

Boston Genomenon and Genetics

‚ÄúThis acquisition builds on our success and puts us at the forefront of the race to cure the entire human genome, bringing unprecedented genomic insights to clinical diagnostics, newborn sequencing and drug development programs. – Mike Klein, CEO ANN ARBOR, Michigan and CAMBRIDGE, Mass. (PRWEB) June 27, 2023 Genomenon Inc., a leader in genomics … Read more